taurocholic acid has been researched along with isoxazoles in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gerok, W; Häussinger, D; Wettstein, M | 1 |
| Gardell, SJ; Tate, SS | 1 |
| Claudel, T; Duval, C; Fruchart, JC; Kosykh, V; Pineda Torra, I; Staels, B | 1 |
| Coelho, AM; da Cunha, JE; de Almeida, JL; Jukemura, J; Machado, MC; Patzina, RA | 1 |
| Armugam, K; Averineni, RK; Meka, SR; Mutalik, S; Nayak, U; Nayanabhirama, U; Pandey, S; Shavi, G; Sunderajan, SG | 1 |
| Kaptanoglu, B; Kutluana, U; Nart, D; Oruc, N; Ozutemiz, O; Yonetci, N | 1 |
| Brouwer, K; Gorczynski, R; Hartman, JC; Mandagere, A; Melvin, L | 1 |
| Brouwer, KR; Gillies, H; Hao, J; Hubert, C; Lepist, EI; Ray, AS; Smith, W; St Claire, RL | 1 |
| Eigner, K; Fruhwürth, S; Röhrl, C; Stangl, H | 1 |
| Anitha, M; Gao, X; Gonzalez, FJ; Jiang, C; Krausz, KW; Patterson, AD; Shi, J; Sun, D; Sun, L; Takahashi, S; Wang, T; Xie, C | 1 |
| Adeli, K; Anakk, S; Baker, C; Dean, AE; Farr, S; Hoffman, S; Masoudpoor, H; Stankovic, B; Taher, J | 1 |
| Camilleri, M; Vijayvargiya, P | 1 |
1 review(s) available for taurocholic acid and isoxazoles
| Article | Year |
|---|---|
The Role of Bile Acids in Chronic Diarrhea.
Topics: Benzothiazoles; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestenones; Cholestyramine Resin; Chronic Disease; Colesevelam Hydrochloride; Colestipol; Diarrhea; Diet, Fat-Restricted; Feces; Humans; Intestinal Mucosa; Irritable Bowel Syndrome; Isoxazoles; Liver; Malabsorption Syndromes; Receptors, Cytoplasmic and Nuclear; Sequestering Agents; Taurocholic Acid | 2020 |
11 other study(ies) available for taurocholic acid and isoxazoles
| Article | Year |
|---|---|
Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Hepatocyte heterogeneity in uptake and biliary excretion.
Topics: Aniline Compounds; Animals; Antimetabolites; Bile; Biological Transport; Chromatography, High Pressure Liquid; gamma-Glutamyltransferase; Isoxazoles; Leukotriene E4; Liver; Male; Perfusion; Rats; Rats, Inbred Strains; SRS-A; Taurocholic Acid | 1989 |
Effects of bile acids and their glycine conjugates on gamma-glutamyl transpeptidase.
Topics: Animals; Benzoates; Benzoic Acid; Bile Acids and Salts; Cholic Acids; gamma-Glutamyltransferase; Glycine; Glycocholic Acid; Hippurates; Isoxazoles; Kidney; Rats; Structure-Activity Relationship; Taurocholic Acid | 1983 |
Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Topics: Animals; Base Sequence; Bile Acids and Salts; Cells, Cultured; Chenodeoxycholic Acid; DNA-Binding Proteins; Gene Expression Regulation; Hepatocytes; Humans; Isoxazoles; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Promoter Regions, Genetic; Receptor Cross-Talk; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Response Elements; Retinoid X Receptors; RNA, Messenger; Species Specificity; Taurocholic Acid; Transcription Factors; Tumor Cells, Cultured | 2003 |
Inhibition of cyclooxygenase-2 in experimental severe acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Interleukin-10; Interleukin-6; Isoxazoles; Male; Pancreatitis; Rats; Rats, Wistar; Survival Rate; Taurocholic Acid | 2006 |
Development of mucoadhesive buccal films for the treatment of oral sub-mucous fibrosis: a preliminary study.
Topics: Adhesiveness; Administration, Buccal; Adult; Animals; Chitosan; Cyclooxygenase Inhibitors; Diffusion; Drug Carriers; Humans; Hypromellose Derivatives; Isoxazoles; Male; Methylcellulose; Mouth Mucosa; Oral Submucous Fibrosis; Sulfonamides; Swine; Taurocholic Acid; Tensile Strength | 2009 |
Leflunomide: is a new oral agent in treatment of acute pancreatitis?
Topics: Administration, Oral; Amylases; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Isoxazoles; Leflunomide; Male; Malondialdehyde; Neutrophil Infiltration; Nitric Oxide; Pancreas; Pancreatitis, Acute Necrotizing; Peroxidase; Pulmonary Edema; Rats; Rats, Wistar; Severity of Illness Index; Taurocholic Acid | 2010 |
Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Bosentan; Cell Culture Techniques; Cells, Cultured; Endothelin Receptor Antagonists; Enkephalin, D-Penicillamine (2,5)-; Estradiol; Female; Hepatocytes; Humans; Isoxazoles; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Organic Anion Transporters, Sodium-Dependent; Phenylpropionates; Pyridazines; Pyrimidines; Sulfonamides; Symporters; Taurocholic Acid; Thiophenes; Young Adult | 2010 |
Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Bile Acids and Salts; Bosentan; Endothelin Receptor Antagonists; Female; Hepatocytes; Humans; Isoxazoles; Liver; Liver-Specific Organic Anion Transporter 1; Male; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organic Anion Transporters; Organic Anion Transporters, Sodium-Dependent; Organic Anion Transporters, Sodium-Independent; Phenylpropionates; Pyridazines; Pyrimidines; Receptors, Endothelin; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfonamides; Symporters; Taurocholic Acid; Thiophenes | 2014 |
Bile acids reduce endocytosis of high-density lipoprotein (HDL) in HepG2 cells.
Topics: Bile Acids and Salts; CD36 Antigens; Chenodeoxycholic Acid; Endocytosis; Hep G2 Cells; Humans; Isoxazoles; Lipoproteins, HDL; Receptors, Cytoplasmic and Nuclear; Scavenger Receptors, Class B; Taurocholic Acid; Transferrin | 2014 |
An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice.
Topics: Acetyl Coenzyme A; Amidohydrolases; Animals; Body Weight; Caffeic Acids; Ceramides; Diet, High-Fat; Gastrointestinal Microbiome; Gluconeogenesis; Ileum; Insulin; Intestinal Mucosa; Intestines; Isoxazoles; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Phenylethyl Alcohol; Pyruvate Carboxylase; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Taurocholic Acid | 2017 |
Bile acid treatment and FXR agonism lower postprandial lipemia in mice.
Topics: Animals; Bile Acids and Salts; Cholesterol 7-alpha-Hydroxylase; Deoxycholic Acid; Exenatide; Gastric Emptying; Gene Expression Regulation; Hyperlipidemias; Insulin; Intestinal Mucosa; Intestines; Isoxazoles; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Postprandial Period; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Taurocholic Acid | 2020 |